Vaxart's VXA-A1.1 vaccine meets in Phase II influenza trial

By Claire Quang | Feb 16, 2018 | 5:32 PM GMT

In October, Vaxart Inc. (San Francisco, Calif.) reported top-line data from a Phase II trial in about